GDPR: The Implications for Clinical Development
Eight months in, Nigel Hughes, Scientific Director JCI-PDR, Janssen, examines the ramifications of GDPR on...
Eight months in, Nigel Hughes, Scientific Director JCI-PDR, Janssen, examines the ramifications of GDPR on...
Topias Lemetyinen, Senior Epidemiologist, GlobalData, explains why HCV continues to be an enduring issue in...
In this Industry Viewpoint, Sarah Fal speaks to Kumar Komuravelli, Mallinckrodt Pharmaceuticals, on the arising...
CTA Editor Henry Kerali explores what impact blockchain could have on clinical research
Paul Jeng, PhD, Infectious Diseases Analyst, GlobalData, analyzes Moderna Therapeutics’ growing stature as the young...
CTA’s Sarah Fal interviews Terry Katz, Merck Animal Health, on the latest clinical data management...
Audrey Hill, Senior Director, Data Management, Advaxis, Inc., explains the keys to clear communication in...
Eric Van Ganse, Manon Belhassen, PELyon, & Francois Gavini, Roche, explain how French national claims...
Alessio Brunello, MSc, Neurology & Ophthalmology Analyst, GlobalData, explores the implications of Janssen’s decision to...
CTA highlights the best articles from the month of June 2018